Effects of Stereotype Threat on Impulsivity and Its Relation to Alcohol Use in African Americans: An fMRI Study
Sponsor
Icahn School of Medicine at Mount Sinai (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05675332
Collaborator
National Institute on Alcohol Abuse and Alcoholism (NIAAA) (NIH)
280
1
2
37.7
7.4
Study Details
Study Description
Brief Summary
The purpose of this study is to investigate the behavioral and neural correlates of stress exposure. Results from this study will enrich the understanding of how sociocultural, behavioral, and neural factors combine to influence alcohol use.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Study Type:
Interventional
Anticipated Enrollment
:
280 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Other
Official Title:
Effects of Stereotype Threat on Impulsivity and Its Relation to Alcohol Use in African Americans: An fMRI Study
Actual Study Start Date
:
Dec 9, 2022
Anticipated Primary Completion Date
:
Jan 31, 2026
Anticipated Study Completion Date
:
Jan 31, 2026
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Placebo Comparator: no stress exposure no threat stress |
Behavioral: Task-based behavioral intervention
Brief behavioral intervention is absent of stressors.
|
Active Comparator: stress exposure exposure to stress threat |
Behavioral: Task-based behavioral intervention
Brief behavioral intervention involves interacting with common everyday types of stress.
|
Outcome Measures
Primary Outcome Measures
- Blood oxygen-level dependent (BOLD) signal [Baseline]
Blood oxygen-level dependent (BOLD) signal in brain regions of interest (ROI) measured using fMRI
- Resting-state functional connectivity in brain regions [Baseline]
Resting-state functional connectivity - brain activity measured using fMRI
Eligibility Criteria
Criteria
Ages Eligible for Study:
21 Years
to 35 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
-
Between 21 and 35 years of age (inclusive);
-
Fluent in English;
-
Right-handed
Exclusion Criteria:
-
Younger than 21 years of age;
-
Left-handed
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Icahn School of Medicine at Mount Sinai | New York | New York | United States | 10029 |
Sponsors and Collaborators
- Icahn School of Medicine at Mount Sinai
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Investigators
- Principal Investigator: Uraina Clark, PhD, Icahn School of Medicine at Mount Sinai
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Uraina S Clark,
Associate Professor,
Icahn School of Medicine at Mount Sinai
ClinicalTrials.gov Identifier:
NCT05675332
Other Study ID Numbers:
- GCO 19-0250
- R01AA028023
First Posted:
Jan 9, 2023
Last Update Posted:
Jan 9, 2023
Last Verified:
Dec 15, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms: